Technology that Identifies Ovarian Cancer at an Early Stage

We have identified three antigens that possess the potential for predicting recurrence at an early time, allowing for early therapeutic intervention.

View our Technology

OvaDx: The Future of Ovarian Cancer Screenings

With a just a few drops of blood, OvaDx measures stable serum biomarkers, while reducing false positives.

Learn More

Focused on Diagnostic Testing for Early Disease Detection

At Avant Diagnostics, we develop specialized medical tests with cutting-edge technology that detect diseases very early in their progression.

Learn More

Stock Information

View Detailed Stock Info
OTCBB: AVDX Avant Diagnostics, Inc.
Change
Volume
Day Range
52 Week Range

Upcoming Events

NobleCon12

Sandpiper Bay, Florida